Home

Overview

MDY Healthcare plc is a sector specialised investing company quoted on AIM (ticker symbol: MDY).  The company seeks to achieve superior returns for shareholders by investing globally in companies, both public and private, across the healthcare sector.  The directors, executives and senior advisors have significant operational and investment experience in the sector and therefore the ability to identify and review a wide range of potential investments.  Given the management’s experience and contact base within the sector, MDY is also able to provide investee companies with strategic business support and advice over and above finance.    

History

The company, previously known as Medisys plc, was listed on the Main Market of the London Stock Exchange in June 2000. Following the sale of its main operating subsidiary, Hypoguard Limited, to ARKRAY Inc. of Japan in May 2006, the company became an investing company. In September 2006, simultaneous with the
move across to AIM and the change of name, the company raised £4.7 million (£4.4 million net of expenses) through a subscription
for new shares by 3i Group plc and the management team.

Investment Strategy

The company identifies investment opportunities, both individually and as a co-investor in companies in the following sub sectors:

  • Medical Technology
  • Diagnostics
  • Biopharmaceuticals and other specialty pharmaceuticals
  • Providers of other healthcare products and services

The company will consider investments in both private and publicly traded companies located in:

  • UK
  • Continental Europe
  • Scandinavia
  • North America
  • Far East
  • Asia
Stanhope Gate